PeopleDouglas Thomson
Douglas Thomson
Douglas ThomsonChief Executive OfficerDouglas Thomson is Chief Executive Officer and co-founder at Pneumagen. His background is in infectious disease vaccine research and development. He was previously at SingVax, in Singapore, as CEO, and Microscience Ltd as Business Development Director. Douglas currently sits on the board of Omideon, a St. Andrews based biotech company focused on the development of novel treatments for cancer; he is a non-executive director of EnteroBiotix, a microbiome therapeutics platform and product company and is a Venture Partner with the KAMRA fund, which is focused on infectious disease.
active0
Roles
team_memberexecutivefounder
Timeline
Current Company
